# 22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions

> **NCT07012694** · NA · NOT_YET_RECRUITING · sponsor: **Huazhong University of Science and Technology** · enrollment: 576 (estimated)

## Conditions studied

- Pancreatic Neoplasms
- Mediastinal Neoplasms
- Abdominal Neoplasm, Excluding Pancreas Neoplasm

## Interventions

- **DEVICE:** 22G Franseen Needle Group
- **DEVICE:** 22G Adapt Needle Group

## Key facts

- **NCT ID:** NCT07012694
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2026-09
- **Final completion:** 2026-12-10
- **Target enrollment:** 576 (ESTIMATED)
- **Last updated:** 2025-07-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07012694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07012694, "22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07012694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*